Columnist Sam Kirton explores what options are available to help IPF patients meet the costs of their medical care and medications.

Interim data from Phase 1 with single and multiple ascending doses show no safety signals and a generally favorable tolerability profile of ...

UNAGI, a deep generative neural network, tracks IPF progression and identifies potential therapies by analyzing cell types and disease-related genes. The model autonomously learns and refines itself, ...

Discover the hidden triggers of idiopathic pulmonary fibrosis (IPF) in your home. Learn to minimize risks from scents, cleaning products, allergens, GERD, and infections.

Please provide your email address to receive an email when new articles are posted on . Patients with idiopathic pulmonary fibrosis coughed fewer times per hour after receiving a 14-day morphine ...

Acute flares of idiopathic pulmonary fibrosis have a mortality rate as high as 90% or more, depending on their severity. But an experimental regimen that includes autoantibody reduction was found to ...

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with ...

Time felt like it was moving in slow motion for columnist Samuel Kirton after his IPF diagnosis. A lung transplant changed everything.